文献速递帕金森病与运动障碍

帕金森病睡眠问题与下丘脑多巴胺D3受体可用性相关

Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
PubMed 文献 · Neurology · 2016-11-02

结果发现较低的D3受体可用性与日间过度嗜睡严重程度相关,但与入睡困难或失眠无关。

要点

  • 下丘脑D3受体可用性降低与帕金森病日间过度嗜睡相关。
  • D3受体可用性与入睡困难或失眠无显著关联。
  • 选择性调节多巴胺D3系统或可改善帕金森病日间警觉性。

核心结论

  • 在帕金森病患者中,日间过度嗜睡的发生与下丘脑多巴胺D3受体可用性降低相关。

研究设计与样本

  • 睡眠问题严重程度采用统一帕金森病评定量表第一部分(患者问卷)的适当子项和Epworth嗜睡量表评定。

主要发现

  • [11C]-PHNO PET测量的较低多巴胺D3受体可用性与更严重的日间过度嗜睡相关。
  • 较低多巴胺D3受体可用性与入睡困难或失眠问题无关。

临床怎么用

  • 对于帕金森病日间过度嗜睡患者,可考虑多巴胺D3系统作为潜在治疗靶点。
  • 选择性药物调节多巴胺D3系统可能用于提高帕金森病患者日间警觉性,但需在更大样本中验证。

局限性

  • 需结合多导睡眠图特征在更大队列中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the relationship between hypothalamic D3 dopamine receptor availability and severity of sleep problems in Parkinson disease (PD). METHODS: Twelve patients were assessed with PET and the high-affinity dopamine D3 receptor radioligand [11C]-propyl-hexahydro-naphtho-oxazin ([11C]-PHNO). Severity of sleep problems was rated with appropriate subitems of the Unified Parkinson's Disease Rating Scale part I (patient questionnaire) and the Epworth Sleepiness Scale. RESULTS: We found that lower dopamine D3 receptor availability measured with [11C]-PHNO PET was associated with greater severity of excessive daytime sleepiness but not with problems of falling asleep or insomnia. CONCLUSION: In our cohort of patients with PD, the occurrence of excessive daytime sleepiness was linked to reductions in hypothalamic dopamine D3 receptor availability. If these preliminary findings are confirmed in larger cohorts of patients with polysomnographic characterization, selective pharmacologic modulation of the dopaminergic D3 system could be used to increase daytime alertness in patients with PD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Pagano G, Molloy S, Bain PG, et al. Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease. Neurology. 2016. PMID: 27807182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。